Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when COSM files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCosmos Health reports record Q1 revenue up 31% to $17.9M, cuts liabilities by $4.5M
Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read
Key Changes
-
high
First quarter 2026 revenue jumped 31% year-over-year to $17.9 million, marking a new Q1 record for the pharmaceutical company.
Item 2.02 verify on EDGAR → -
high
Total liabilities decreased by $4.5 million during the quarter, improving the company's balance sheet position.
Exhibit 99.1 view on EDGAR → -
medium
Stockholders' equity increased 7.6% as the company strengthened its financial position while holding $2.2 million in cash.
Exhibit 99.1 view on EDGAR → -
medium
Management stated record momentum continues into Q2 2026 with U.S. market expansion currently underway.
Exhibit 99.1 view on EDGAR →
Summary
Cosmos Health delivered strong first quarter 2026 results with revenue climbing 31% to a record $17.9 million for any first quarter in company history. The pharmaceutical distributor simultaneously improved its balance sheet by reducing total liabilities by $4.5 million and growing stockholders' equity by 7.6%, while maintaining $2.2 million in cash reserves. For retail investors, these results suggest the company is executing on growth while strengthening its financial foundation—a combination that's often difficult to achieve.
The revenue growth indicates strong demand for the company's pharmaceutical products, while the liability reduction shows management is prioritizing financial health alongside expansion. The key item to watch is whether the company can sustain this momentum through Q2 2026 as it pursues U.S. market expansion. Investors should look for the Q2 earnings release to confirm whether the growth trajectory continues and whether the U.S. expansion generates meaningful revenue contribution without straining the balance sheet.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Cosmos Health disclosed Q1 2026 financial results via press release for quarter ended March 31, 2026.
Added in current filing · verify on EDGAR →
On May 21, 2026, Cosmos Health Inc. (the “Company”) issued a press release setting forth the financial results for its first fiscal quarter ended March 31, 2026.
The company announced its first quarter 2026 financial results covering the period ended March 31, 2026. The actual financial metrics are contained in the attached press release (Exhibit 99.1), which is not included in this 8-K body text.
Event · Item 9.01 — Financial Statements and Exhibits
Cosmos Health disclosed Q1 2026 results via press release: revenue up 31% to $17.9M, liabilities reduced $4.5M, equity up 7.6%, cash $2.2M.
Added in current filing · verify on EDGAR →
Press Release dated May 21, 2026, entitled “Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5m; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway.”
Cosmos Health announced first quarter 2026 financial results showing revenue increased 31% to $17.9 million, a new Q1 record for the company. Total liabilities decreased by $4.5 million, stockholders' equity rose 7.6%, and the company held $2.2 million in cash. The company indicated record momentum continues into Q2 with U.S. expansion underway.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 25, 2026 · How we verify